[go: up one dir, main page]

YU24201A - Aerosolne čestice otporne na porast higroskopnosti - Google Patents

Aerosolne čestice otporne na porast higroskopnosti

Info

Publication number
YU24201A
YU24201A YU24201A YU24201A YU24201A YU 24201 A YU24201 A YU 24201A YU 24201 A YU24201 A YU 24201A YU 24201 A YU24201 A YU 24201A YU 24201 A YU24201 A YU 24201A
Authority
YU
Yugoslavia
Prior art keywords
dry powder
powder particles
hygroscopic growth
particles resistant
growth
Prior art date
Application number
YU24201A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Andrew Clark
Mei-Chang Kuo
Cecily Lalor
Barry John Aldous
Original Assignee
Inhale Therapeutic Systems Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Systems Inc. filed Critical Inhale Therapeutic Systems Inc.
Publication of YU24201A publication Critical patent/YU24201A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
YU24201A 1998-09-14 1999-09-13 Aerosolne čestice otporne na porast higroskopnosti YU24201A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
YU24201A true YU24201A (sh) 2003-08-29

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
YU24201A YU24201A (sh) 1998-09-14 1999-09-13 Aerosolne čestice otporne na porast higroskopnosti

Country Status (44)

Country Link
EP (1) EP1117442A1 (fr)
JP (1) JP2002524535A (fr)
KR (1) KR20010075063A (fr)
CN (1) CN1317977A (fr)
AP (1) AP1374A (fr)
AR (1) AR022090A1 (fr)
AU (1) AU753014B2 (fr)
BG (1) BG105430A (fr)
BR (1) BR9913722A (fr)
CA (1) CA2343920A1 (fr)
CO (1) CO5130023A1 (fr)
CZ (1) CZ2001829A3 (fr)
DZ (1) DZ2892A1 (fr)
EA (1) EA003476B1 (fr)
EE (1) EE200100151A (fr)
GE (1) GEP20043257B (fr)
GT (1) GT199900156A (fr)
HK (1) HK1042231A1 (fr)
HN (1) HN1999000159A (fr)
HR (1) HRP20010189A2 (fr)
HU (1) HUP0103837A3 (fr)
ID (1) ID28845A (fr)
IL (2) IL141562A0 (fr)
IS (1) IS5878A (fr)
LT (1) LT4897B (fr)
LV (1) LV12658B (fr)
MA (1) MA25590A1 (fr)
MY (1) MY129282A (fr)
NO (1) NO20011251L (fr)
NZ (1) NZ510168A (fr)
OA (1) OA11781A (fr)
PA (1) PA8481901A1 (fr)
PE (1) PE20001061A1 (fr)
PL (1) PL195574B1 (fr)
SA (1) SA99200718B1 (fr)
SK (1) SK3442001A3 (fr)
TN (1) TNSN99173A1 (fr)
TR (1) TR200101182T2 (fr)
TW (1) TWI226248B (fr)
UA (1) UA76085C2 (fr)
UY (1) UY25711A1 (fr)
WO (1) WO2000015262A1 (fr)
YU (1) YU24201A (fr)
ZA (1) ZA200101995B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
AU782916B2 (en) 1999-06-09 2005-09-08 Robert E. Sievers Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
EP1392262A1 (fr) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7182961B2 (en) 2001-11-20 2007-02-27 Advanced Inhalation Research, Inc. Particulate compositions for pulmonary delivery
CZ2004904A3 (cs) 2002-02-25 2004-12-15 Diffusion Pharmaceuticals Llc Bipolární trans karotenoidní soli a jejich použití
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
EP1539246A4 (fr) * 2002-07-03 2007-05-16 Brigham & Womens Hospital Introduction par les voies aeriennes centrales pour l'administration systemique d'agents therapeutiques
ES2280835T3 (es) * 2002-12-19 2007-09-16 Pharmacia Corporation Formulacion no higroscopica que comprende un farmaco higroscopico.
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
SI2708225T1 (sl) * 2004-04-23 2019-05-31 Cydex Pharmaceuticals, Inc. Formulacija DPI, ki vsebuje sulfoalkil eter ciklodekstrin
BRPI0608561A2 (pt) * 2005-02-24 2010-01-12 Diffusion Pharmaceuticals Llc trans-carotenóides, sìntese, formulação e usos dos mesmos
CN101171023A (zh) * 2005-03-09 2008-04-30 小野药品工业株式会社 一种粒子以及含有该粒子的制剂
DK2952197T3 (en) 2005-10-26 2017-08-07 Cydex Pharmaceuticals Inc SULPHALYCYLETER CYCLE CODE EXTRACTION COMPOSITION AND PROCEDURE FOR PREPARING THEREOF
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) * 2006-08-14 2008-02-14 Sievers Robert E Human-powered dry powder inhaler and dry powder inhaler compositions
CN101541311B (zh) * 2006-10-25 2013-01-23 大日本住友制药株式会社 不易结块的颗粒制剂
EP1925295A1 (fr) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Formule de poudre stable contenant un nouveau anticholinergique
AU2008246305B2 (en) 2007-04-13 2013-03-21 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
CN101878040A (zh) 2007-10-31 2010-11-03 扩散药品有限公司 一类促进小分子扩散的新型治疗剂
PL2432502T3 (pl) 2009-05-20 2018-05-30 Aeras Trwałe, suszone rozpyłowo, immunogenne kompozycje wirusowe
EP2445339B1 (fr) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Composé améliorant la diffusion et son utilisation avec un thrombolytique
US8974822B2 (en) 2010-06-02 2015-03-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
US9682096B2 (en) 2012-05-02 2017-06-20 Janssen R & D Ireland Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
WO2015042352A1 (fr) * 2013-09-20 2015-03-26 Virginia Commonwealth University Administration de particules à l'aide d'excipients hygroscopiques
CN107106641B (zh) 2014-10-31 2021-12-21 葛兰素史密斯克莱知识产权发展有限公司 粉末制剂
CN115089569A (zh) 2016-03-24 2022-09-23 扩散药品有限公司 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
EP0611567B1 (fr) * 1992-06-12 2002-08-28 Teijin Limited Poudre ultra-fine pour inhalation et production de cette poudre
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
ES2236832T3 (es) * 1997-01-16 2005-07-16 Massachusetts Institute Of Technology Preparacion de particulas para inhalacion.
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
IS5878A (is) 2001-03-05
DZ2892A1 (fr) 2003-12-15
NO20011251D0 (no) 2001-03-13
EA003476B1 (ru) 2003-06-26
TNSN99173A1 (fr) 2005-11-10
IL141562A (en) 2007-07-24
UA76085C2 (en) 2006-07-17
HK1042231A1 (zh) 2002-08-09
CZ2001829A3 (cs) 2001-09-12
NO20011251L (no) 2001-04-17
TR200101182T2 (tr) 2001-09-21
LT4897B (lt) 2002-02-25
PE20001061A1 (es) 2000-10-08
LT2001021A (en) 2001-11-26
OA11781A (en) 2005-07-26
JP2002524535A (ja) 2002-08-06
EP1117442A1 (fr) 2001-07-25
MY129282A (en) 2007-03-30
BG105430A (en) 2001-12-29
BR9913722A (pt) 2001-05-29
UY25711A1 (es) 1999-11-17
PL346768A1 (en) 2002-02-25
CO5130023A1 (es) 2002-02-27
PL195574B1 (pl) 2007-10-31
KR20010075063A (ko) 2001-08-09
HUP0103837A3 (en) 2002-11-28
SK3442001A3 (en) 2001-11-06
WO2000015262A1 (fr) 2000-03-23
AP1374A (en) 2005-02-28
CA2343920A1 (fr) 2000-03-23
MA25590A1 (fr) 2002-12-31
CN1317977A (zh) 2001-10-17
AR022090A1 (es) 2002-09-04
LV12658A (lv) 2001-05-20
HRP20010189A2 (en) 2005-04-30
EE200100151A (et) 2002-06-17
TWI226248B (en) 2005-01-11
AU753014B2 (en) 2002-10-03
SA99200718B1 (ar) 2006-11-04
LV12658B (lv) 2001-09-20
AP2001002093A0 (en) 2001-03-31
IL141562A0 (en) 2002-03-10
AU6039799A (en) 2000-04-03
HUP0103837A2 (hu) 2002-05-29
HN1999000159A (es) 1999-11-11
PA8481901A1 (es) 2002-04-25
ZA200101995B (en) 2002-03-11
NZ510168A (en) 2003-09-26
GEP20043257B (en) 2004-06-25
EA200100300A1 (ru) 2001-10-22
GT199900156A (es) 2001-03-07
ID28845A (id) 2001-07-05

Similar Documents

Publication Publication Date Title
MY129282A (en) Aerosolizable particles resistant to hygroscopic growth
NZ511527A (en) Dry powder for inhalation
MY129112A (en) Flow resistance modulated aerosolized active agent delivery
HU9201521D0 (en) Stimulating unit containing nicotine
GB1484781A (en) Compositions for dental treatment
CA2412561A1 (fr) Distribution hautement efficace d'une grande quantite d'aerosol therapeutique
HRP20010463B1 (hr) Smjesa s kontroliranim otpuštanjem koja sadrži galantamin
NO20004980D0 (no) Partikulær virkestoffbærer for pulmonær anvendelse
CA2488976A1 (fr) Epinephrine pouvant etre inhalee
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ATE150310T1 (de) Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
AU6611998A (en) Therapeutic powder formulation for pulmonary administration, containing crystalline insulin
ID22883A (id) Formulasi untuk inhalasi yang memiliki densitas ruah terlimpah antara 0,28 sampai 038 g/ml dan mengandung budesonida
MXPA05009629A (es) Composiciones que contienen trospio.
HU201685B (en) For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
WO2005039288A3 (fr) Composition insecticide a activite synergique renforcee
PL365736A1 (en) Bimodal dry powder formulation for inhalation
SE8300495L (sv) Forbettringar av eller i samband med nasala farmaceutiska kompositioner
TH51990A3 (th) การปล่อยสารออกฤทธิ์ที่เป็นผงแห้ง
PL393880A1 (pl) Zastosowanie kompozycji herbicydów do zwalczania szkodliwych roślin w uprawach zbóż, sposób zwalczania szkodliwych roślin w tolerujących uprawach zbóż, preparat chwastobójczy i jego zastosowanie